Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUPV
2376
Grupo Supervielle
SUPV
$469M
| $2.21M | ﹤0.01% |
311,427
+54,599
| +21% | +$388K |
|
2377
NCR Atleos
NATL
$2.92B
| $2.21M | ﹤0.01% |
77,490
-238,439
| -75% | -$6.8M |
|
2378
Lexicon Pharmaceuticals
LXRX
$407M
| $2.2M | ﹤0.01% |
1,398,876
+801,555
| +134% | +$1.26M |
|
2379
iShares MSCI USA Value Factor ETF
VLUE
$7.28B
| $2.19M | ﹤0.01% |
20,110
+1,236
| +7% | +$135K |
|
2380
Encore Capital Group
ECPG
$1.03B
| $2.19M | ﹤0.01% |
46,370
-33,800
| -42% | -$1.6M |
|
2381
Invesco S&P 500 Equal Weight ETF
RSP
$74.6B
| $2.19M | ﹤0.01% |
12,231
-131,565
| -91% | -$23.6M |
|
|
IGMS
2382
DELISTED
IGM Biosciences
IGMS
| $2.19M | ﹤0.01% |
132,342
-258,871
| -66% | -$4.28M |
|
2383
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.7B
| $2.18M | ﹤0.01% |
+64,753
| New | +$2.18M |
|
2384
XBiotech
XBIT
$82.9M
| $2.17M | ﹤0.01% |
281,019
-80,642
| -22% | -$623K |
|
2385
Horizon Technology Finance
HRZN
$291M
| $2.17M | ﹤0.01% |
+203,424
| New | +$2.17M |
|
2386
CION Investment
CION
$509M
| $2.15M | ﹤0.01% |
180,892
-40,990
| -18% | -$488K |
|
2387
Vanguard Value ETF
VTV
$145B
| $2.15M | ﹤0.01% |
12,322
-31,036
| -72% | -$5.42M |
|
2388
FIGS
FIGS
$1.2B
| $2.15M | ﹤0.01% |
313,747
-309,789
| -50% | -$2.12M |
|
2389
FirstService
FSV
$9.34B
| $2.14M | ﹤0.01% |
11,747
-197,550
| -94% | -$36.1M |
|
2390
Akero Therapeutics
AKRO
$3.43B
| $2.14M | ﹤0.01% |
74,628
-94,963
| -56% | -$2.72M |
|
|
GOGL
2391
DELISTED
Golden Ocean Group
GOGL
| $2.14M | ﹤0.01% |
159,714
+30,566
| +24% | +$409K |
|
2392
CI&T Inc
CINT
$740M
| $2.13M | ﹤0.01% |
314,100
+15,162
| +5% | +$103K |
|
2393
Nabors Energy Transition Corp II
NETD
$240M
| $2.13M | ﹤0.01% |
200,000
| – | – |
|
2394
CarGurus
CARG
$3.59B
| $2.13M | ﹤0.01% |
70,894
-109,110
| -61% | -$3.28M |
|
2395
Rapid7
RPD
$1.26B
| $2.13M | ﹤0.01% |
53,317
-360,163
| -87% | -$14.4M |
|
2396
World Kinect Corp
WKC
$1.41B
| $2.13M | ﹤0.01% |
68,791
-39,979
| -37% | -$1.24M |
|
2397
Corbus Pharmaceuticals
CRBP
$115M
| $2.12M | ﹤0.01% |
102,751
-138,898
| -57% | -$2.87M |
|
2398
South Plains Financial
SPFI
$655M
| $2.11M | ﹤0.01% |
62,349
+25,598
| +70% | +$868K |
|
2399
Magnite
MGNI
$3.38B
| $2.11M | ﹤0.01% |
152,229
+118,511
| +351% | +$1.64M |
|
2400
Cimpress
CMPR
$1.41B
| $2.1M | ﹤0.01% |
25,671
-17,279
| -40% | -$1.42M |
|